T2 Biosystems Inc
TTOO
Market Cap$16.48M
Close$
$3.41
15.1% upside
Current Fair Value
15.1% upsideUndervalued by 15.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $16.48 Million |
|---|---|
| Enterprise Value | $55.10 Million |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-19.19 |
| Beta | 1.11 |
| Outstanding Shares | 5,512,332 |
| Avg 30 Day Volume | 176,462 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -0.33 |
|---|---|
| PEG | -13.79 |
| Price to Sales | 2.96 |
| Price to Book Ratio | -0.49 |
| Enterprise Value to Revenue | 7.66 |
| Enterprise Value to EBIT | -1.17 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.99 |
| Debt to Equity | -1.94 |
Revenue Sources
No data
ESG Score
No data
About T2 Biosystems Inc
CEO: John Sperzel